Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc.（DAWN）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
dawn · 股价预测 · 12 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 12 位华尔街分析师
Buy
12 位分析师
共识
评级分布
12 个月目标价
High
$21.50
Consensus
$21.50
-0.1% upside
Low
$21.50
Median: $21.5 · Last Close: $21.53
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $21.52 | ↓ 0.04% |
1-day model range: $21.52–$21.53. Peak: $21.53 (-0.04%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · DAWN · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-11 | JP Morgan | Downgrade ↓ | Overweight→Neutral |
| 2026-03-10 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2026-03-09 | Wedbush | Downgrade ↓ | Outperform→Neutral |
| 2026-03-06 | Jones Trading | Downgrade ↓ | Buy→Hold |
| 2026-03-06 | Needham | Downgrade ↓ | Buy→Hold |
| 2026-02-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-25 | Wedbush | Maintains | Outperform→Outperform |
| 2026-02-25 | Needham | Maintains | Buy→Buy |
| 2025-11-24 | Needham | Maintains | Buy→Buy |
| 2025-11-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Day One Biopharmaceuticals, Inc. (DAWN) stock. Of the recent 78 rating actions, 1 were upgrades and 6 were downgrades. 12 analysts currently cover DAWN.
分析师推荐趋势
DAWN analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$240M
↓ 39.7% YoY
Revenue Next Year
$308M
↑ 28.1% YoY
EPS This Year
$-0.78
EPS Next Year
$-0.18
↓ 76.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast DAWN EPS of $-0.78 for the current fiscal year, based on estimates from 6 analysts. The DAWN revenue forecast is $240M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
DAWN 股价预测由两类独立数据源支撑：来自 12 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。DAWN 的共识目标价为 $21.50（-0.1% 上行空间），分析师共识为 Buy。
DAWN 的短期预测（明日）为 $21.52（-0.04%）。
Day One Biopharmaceuticals, Inc. 在 NASDAQ 上市，代码 DAWN。DAWN 在 2027 年的整体展望偏积极，在覆盖分析师中约 50% 对应 Buy 共识。
常见问题
DAWN 预测 · 8 个问题根据 12 位华尔街分析师，DAWN 的 12 个月平均目标价为 $21.50，最高 $21.50、最低 $21.50。若有图表，中位目标价可在上方查看。相对当前价 $21.53，隐含约 -0.1% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.